CD4 and malaria: Polyfunctional analysis of the ICS data of the later study showed that IFN-γ-IL-2−TNF-α+ CD4+ T cells independently predicted reduced risk of clinical malaria, although the response was also detected in control vaccinees, and found a synergistic interaction with anti-CSP IgG titers (9).